218 related articles for article (PubMed ID: 10226097)
1. Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody.
Szebeni J; Fontana JL; Wassef NM; Mongan PD; Morse DS; Dobbins DE; Stahl GL; Bünger R; Alving CR
Circulation; 1999 May; 99(17):2302-9. PubMed ID: 10226097
[TBL] [Abstract][Full Text] [Related]
2. Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction.
Szebeni J; Baranyi L; Savay S; Bodo M; Morse DS; Basta M; Stahl GL; Bünger R; Alving CR
Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H1319-28. PubMed ID: 10993799
[TBL] [Abstract][Full Text] [Related]
3. Complement activation-related cardiac anaphylaxis in pigs: role of C5a anaphylatoxin and adenosine in liposome-induced abnormalities in ECG and heart function.
Szebeni J; Baranyi L; Sávay S; Bodó M; Milosevits J; Alving CR; Bünger R
Am J Physiol Heart Circ Physiol; 2006 Mar; 290(3):H1050-8. PubMed ID: 16214844
[TBL] [Abstract][Full Text] [Related]
4. Acute physiological changes caused by complement activators and amphotericin B-containing liposomes in mice.
Őrfi E; Mészáros T; Hennies M; Fülöp T; Dézsi L; Nardocci A; Rosivall L; Hamar P; Neun BW; Dobrovolskaia MA; Szebeni J; Szénási G
Int J Nanomedicine; 2019; 14():1563-1573. PubMed ID: 30880965
[TBL] [Abstract][Full Text] [Related]
5. Cardiopulmonary hemodynamic responses to the small injection of hemoglobin vesicles (artificial oxygen carriers) in miniature pigs.
Sakai H; Suzuki Y; Sou K; Kano M
J Biomed Mater Res A; 2012 Oct; 100(10):2668-77. PubMed ID: 22615268
[TBL] [Abstract][Full Text] [Related]
6. Involvement of complement activation in the pulmonary vasoactivity of polystyrene nanoparticles in pigs: unique surface properties underlying alternative pathway activation and instant opsonization.
Mészáros T; Kozma GT; Shimizu T; Miyahara K; Turjeman K; Ishida T; Barenholz Y; Urbanics R; Szebeni J
Int J Nanomedicine; 2018; 13():6345-6357. PubMed ID: 30349254
[TBL] [Abstract][Full Text] [Related]
7. Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses.
Dézsi L; Fülöp T; Mészáros T; Szénási G; Urbanics R; Vázsonyi C; Őrfi E; Rosivall L; Nemes R; Kok RJ; Metselaar JM; Storm G; Szebeni J
J Control Release; 2014 Dec; 195():2-10. PubMed ID: 25148822
[TBL] [Abstract][Full Text] [Related]
8. Hypersensitivity reactions to intravenous lipid emulsion in swine: relevance for lipid resuscitation studies.
Bedocs P; Capacchione J; Potts L; Chugani R; Weiszhar Z; Szebeni J; Buckenmaier CC
Anesth Analg; 2014 Nov; 119(5):1094-101. PubMed ID: 25126705
[TBL] [Abstract][Full Text] [Related]
9. Complement activation and thromboxane secretion by liposome-encapsulated hemoglobin in rats in vivo: inhibition by soluble complement receptor type 1.
Szebeni J; Spielberg H; Cliff RO; Wassef NM; Rudolph AS; Alving CR
Artif Cells Blood Substit Immobil Biotechnol; 1997 Jul; 25(4):347-55. PubMed ID: 9242930
[TBL] [Abstract][Full Text] [Related]
10. C5a/C5ades-Arg-induced increase in blood pressure in the guinea pig: role of thromboxane.
Fraser DG; Regal JF
Immunopharmacology; 1990; 19(1):59-68. PubMed ID: 1968450
[TBL] [Abstract][Full Text] [Related]
11. Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention.
Szebeni J; Muggia F; Gabizon A; Barenholz Y
Adv Drug Deliv Rev; 2011 Sep; 63(12):1020-30. PubMed ID: 21787819
[TBL] [Abstract][Full Text] [Related]
12. Complement Activation-Related Pathophysiological Changes in Anesthetized Rats: Activator-Dependent Variations of Symptoms and Mediators of Pseudoallergy.
Dézsi L; Mészáros T; Őrfi E; Fülöp TG; Hennies M; Rosivall L; Hamar P; Szebeni J; Szénási G
Molecules; 2019 Sep; 24(18):. PubMed ID: 31505853
[TBL] [Abstract][Full Text] [Related]
13. Prevention of the hemodynamic effects of iopromide-carrying liposomes in rats and pigs.
Krause W; Gerlach S; Muschick P
Invest Radiol; 2000 Aug; 35(8):493-503. PubMed ID: 10946977
[TBL] [Abstract][Full Text] [Related]
14. Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles.
Szebeni J; Alving CR; Rosivall L; Bünger R; Baranyi L; Bedöcs P; Tóth M; Barenholz Y
J Liposome Res; 2007; 17(2):107-17. PubMed ID: 17613700
[TBL] [Abstract][Full Text] [Related]
15. A porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicines.
Szebeni J; Bedőcs P; Csukás D; Rosivall L; Bünger R; Urbanics R
Adv Drug Deliv Rev; 2012 Dec; 64(15):1706-16. PubMed ID: 22820530
[TBL] [Abstract][Full Text] [Related]
16. Prevention of infusion reactions to PEGylated liposomal doxorubicin via tachyphylaxis induction by placebo vesicles: a porcine model.
Szebeni J; Bedőcs P; Urbanics R; Bünger R; Rosivall L; Tóth M; Barenholz Y
J Control Release; 2012 Jun; 160(2):382-7. PubMed ID: 22421426
[TBL] [Abstract][Full Text] [Related]
17. Complement activation in vitro by the red cell substitute, liposome-encapsulated hemoglobin: mechanism of activation and inhibition by soluble complement receptor type 1.
Szebeni J; Wassef NM; Hartman KR; Rudolph AS; Alving CR
Transfusion; 1997 Feb; 37(2):150-9. PubMed ID: 9051089
[TBL] [Abstract][Full Text] [Related]
18. Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome.
Szebeni J; Bedocs P; Rozsnyay Z; Weiszhár Z; Urbanics R; Rosivall L; Cohen R; Garbuzenko O; Báthori G; Tóth M; Bünger R; Barenholz Y
Nanomedicine; 2012 Feb; 8(2):176-84. PubMed ID: 21704590
[TBL] [Abstract][Full Text] [Related]
19. Complement activation as a bioequivalence issue relevant to the development of generic liposomes and other nanoparticulate drugs.
Szebeni J; Storm G
Biochem Biophys Res Commun; 2015 Dec; 468(3):490-7. PubMed ID: 26182876
[TBL] [Abstract][Full Text] [Related]
20. Complement activation and membrane lipids in lung vascular injury.
Lundberg C; Gardinali M; Hugli TE
Am Rev Respir Dis; 1987 Aug; 136(2):459-62. PubMed ID: 3619209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]